Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand

被引:24
作者
Azahri, Nor Saadah M. [1 ,2 ,3 ]
Kavurma, Mary M. [1 ]
机构
[1] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia
[3] Int Islamic Univ, Fac Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia
关键词
TRAIL; Transcription factor; Regulation; Gene expression; Apoptosis; Cell survival; NF-KAPPA-B; TRAIL-INDUCED APOPTOSIS; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; INFLUENZA-VIRUS PROPAGATION; HUMAN ENDOTHELIAL-CELLS; HUMAN T-CELLS; GENE-EXPRESSION; MEDIATED APOPTOSIS; DEATH DOMAIN;
D O I
10.1007/s00018-013-1264-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) has dual functions mediating both apoptosis and survival of cells. This review focusses on the current regulatory factors that control TRAIL transcription. Here, we also highlight the role of distinct transcription factors that co-operate and regulate TRAIL in different pathological states. A better understanding of the molecular signalling pathways of TRAIL-induced cell death and survival in disease may lead to more sophisticated technologies for novel therapeutic targets.
引用
收藏
页码:3617 / 3629
页数:13
相关论文
共 102 条
[1]
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy [J].
Almasan, A ;
Ashkenazi, A .
CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) :337-348
[2]
Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]
Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement [J].
Azab, Noha A. ;
Rady, Hanaa M. ;
Marzouk, Samar A. .
CLINICAL RHEUMATOLOGY, 2012, 31 (09) :1359-1364
[4]
Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: Mechanisms of PDGF-BB-mediated VSMC proliferation and migration [J].
Azahri, Nor Saadah M. ;
Di Bartolo, Belinda A. ;
Khachigian, Levon M. ;
Kavurma, Mary M. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2012, 113 (08) :2597-2606
[5]
Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects [J].
Baader, E ;
Toloczko, A ;
Fuchs, U ;
Schmid, I ;
Beltinger, C ;
Ehrhardt, H ;
Debatin, KM ;
Jeremias, I .
CANCER RESEARCH, 2005, 65 (17) :7888-7895
[6]
Disruption of NF-κB signaling reveals a novel role for NF-κB in the regulation of TNF-related apoptosis-inducing ligand expression [J].
Baetu, TM ;
Kwon, H ;
Sharma, S ;
Grandvaux, N ;
Hiscott, J .
JOURNAL OF IMMUNOLOGY, 2001, 167 (06) :3164-3173
[7]
TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges [J].
Bellail, Anita C. ;
Qi, Ling ;
Mulligan, Patrick ;
Chhabra, Vaninder ;
Hao, Chunhai .
REVIEWS ON RECENT CLINICAL TRIALS, 2009, 4 (01) :34-41
[8]
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand [J].
Carlo-Stella, Carmelo ;
Lavazza, Cristiana ;
Di Nicola, Massimo ;
Cleris, Loredana ;
Longoni, Paolo ;
Milanesi, Marco ;
Magni, Michele ;
Morelli, Daniele ;
Gloghini, Annunziata ;
Carbone, Antonino ;
Gianni, Alessandro M. .
HUMAN GENE THERAPY, 2006, 17 (12) :1225-1240
[9]
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies [J].
Castellino, G. ;
Corallini, F. ;
Trottal, F. ;
Secchiero, P. .
LUPUS, 2007, 16 (07) :479-482
[10]
TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2-, Sp1 Phosphorylation-, and NFκB-Dependent Manner [J].
Chan, Jeffrey ;
Prado-Lourenco, Leonel ;
Khachigian, Levon M. ;
Bennett, Martin R. ;
Di Bartolo, Belinda A. ;
Kavurma, Mary M. .
CIRCULATION RESEARCH, 2010, 106 (06) :1061-1071